Integra LifeSciences Holdings (IART) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Integra LifeSciences Holdings (IART) has a cash flow conversion efficiency ratio of 0.009x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($9.80 Million) by net assets ($1.04 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Integra LifeSciences Holdings fund operations to measure how many days the company can operate on defensive assets alone.
Integra LifeSciences Holdings - Cash Flow Conversion Efficiency Trend (1995–2025)
This chart illustrates how Integra LifeSciences Holdings's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Integra LifeSciences Holdings Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Integra LifeSciences Holdings ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Paymentus Holdings, Inc.
NYSE:PAY
|
0.052x |
|
IRSA Inversiones Y Representaciones
NYSE:IRS
|
-0.026x |
|
Nanjing Sciyon Automation Group Co Ltd
SHE:002380
|
0.148x |
|
Bank Pan Indonesia Tbk
JK:PNBN
|
0.020x |
|
PCBL LIMITED
NSE:PCBL
|
0.205x |
|
Jintuo Technology Co Ltd
SHG:603211
|
N/A |
|
Changsha DIALINE New Material Sci & Tech Co Ltd
SHE:300700
|
-0.041x |
|
Wuxi Zhenhua Auto Parts Co. Ltd.
SHG:605319
|
0.081x |
Annual Cash Flow Conversion Efficiency for Integra LifeSciences Holdings (1995–2025)
The table below shows the annual cash flow conversion efficiency of Integra LifeSciences Holdings from 1995 to 2025. For the full company profile with market capitalisation and key ratios, see Integra LifeSciences Holdings (IART) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $1.04 Billion | $50.38 Million | 0.048x | -42.33% |
| 2024-12-31 | $1.55 Billion | $129.38 Million | 0.084x | -5.01% |
| 2023-12-31 | $1.59 Billion | $139.96 Million | 0.088x | -39.86% |
| 2022-12-31 | $1.80 Billion | $264.47 Million | 0.147x | -20.96% |
| 2021-12-31 | $1.68 Billion | $312.43 Million | 0.185x | +37.82% |
| 2020-12-31 | $1.51 Billion | $203.83 Million | 0.135x | -17.63% |
| 2019-12-31 | $1.42 Billion | $231.43 Million | 0.163x | +12.55% |
| 2018-12-31 | $1.38 Billion | $199.68 Million | 0.145x | +21.93% |
| 2017-12-31 | $962.31 Million | $114.54 Million | 0.119x | -14.14% |
| 2016-12-31 | $839.67 Million | $116.41 Million | 0.139x | +10.26% |
| 2015-12-31 | $751.44 Million | $94.48 Million | 0.126x | +11.45% |
| 2014-12-31 | $704.32 Million | $79.46 Million | 0.113x | +41.94% |
| 2013-12-31 | $670.18 Million | $53.27 Million | 0.079x | -29.91% |
| 2012-12-31 | $517.77 Million | $58.72 Million | 0.113x | -46.45% |
| 2011-12-31 | $492.64 Million | $104.33 Million | 0.212x | +0.29% |
| 2010-12-31 | $499.96 Million | $105.57 Million | 0.211x | -34.41% |
| 2009-12-31 | $444.88 Million | $143.24 Million | 0.322x | +55.33% |
| 2008-12-31 | $350.21 Million | $72.59 Million | 0.207x | +14.79% |
| 2007-12-31 | $260.43 Million | $47.03 Million | 0.181x | -25.42% |
| 2006-12-31 | $296.16 Million | $71.70 Million | 0.242x | +23.43% |
| 2005-12-31 | $289.82 Million | $56.85 Million | 0.196x | +54.92% |
| 2004-12-31 | $307.82 Million | $38.98 Million | 0.127x | -2.37% |
| 2003-12-31 | $268.53 Million | $34.83 Million | 0.130x | +0.39% |
| 2002-12-31 | $247.60 Million | $31.98 Million | 0.129x | +67.89% |
| 2001-12-31 | $204.06 Million | $15.70 Million | 0.077x | +183.43% |
| 2000-12-31 | $53.78 Million | $-4.96 Million | -0.092x | -240.18% |
| 1999-12-31 | $38.00 Million | $2.50 Million | 0.066x | +121.08% |
| 1998-12-31 | $31.40 Million | $-9.80 Million | -0.312x | -41.43% |
| 1997-12-31 | $35.80 Million | $-7.90 Million | -0.221x | -27.99% |
| 1996-12-31 | $46.40 Million | $-8.00 Million | -0.172x | +46.43% |
| 1995-12-31 | $17.40 Million | $-5.60 Million | -0.322x | -- |
About Integra LifeSciences Holdings
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural … Read more